RGEN insider transaction filings
REPLIGEN CORP — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen RGEN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Loeillot Olivier — Chief Executive Officer, Director | Option exercise (M): 5,426 @ $141.79 · Sale (S): 5,426 @ $180 · Option exercise (M): 5,426 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Garland Jason K — CFO | Sale (S): 530 @ $150 | EDGAR |
| 2026-06-26 | 4 | Garland Jason K — CFO | Sale (S): 733 @ $145 | EDGAR |
| 2026-05-18 | 4 | Pax Margaret — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Mhatre Rohin — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Konstantinov Konstantin — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | EGLINTON MANNER CARRIE — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Madaus Martin D — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | BARTHELEMY NICOLAS — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | DAWES KAREN A — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | MUIR GLENN P — Director | Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Douglass Brian Robb — CHIEF PRODUCT OFFICER | Tax withholding (F): 334 @ $126.43 | EDGAR |
| 2026-05-08 | 4 | MUIR GLENN P — Director | Option exercise (M): 2,434 @ $38.76 · Option exercise (M): 2,434 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Loeillot Olivier — Chief Executive Officer, Director | Sale (S): 3,832 @ $140 | EDGAR |
| 2026-03-23 | 4 | Loeillot Olivier — Chief Executive Officer | Grant/award (A): 24,134 @ $0 · Grant/award (A): 25,890 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Bylund James — Chief Operating Officer | Grant/award (A): 7,751 @ $0 · Grant/award (A): 8,315 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Garland Jason K — CFO | Grant/award (A): 7,751 @ $0 · Grant/award (A): 8,315 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | KURIYEL RALF — Senior VP, R&D | Grant/award (A): 5,284 @ $0 · Grant/award (A): 5,669 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Bylund James — Chief Operating Officer | Grant/award (A): 125 @ $0 · Tax withholding (F): 62 @ $125.84 | EDGAR |
| 2026-03-05 | 4 | KURIYEL RALF — Senior VP, R&D | Grant/award (A): 125 @ $0 · Tax withholding (F): 42 @ $125.84 | EDGAR |
| 2026-03-03 | 4 | Douglass Brian Robb — CHIEF PRODUCT OFFICER | Tax withholding (F): 221 @ $124.97 | EDGAR |
| 2026-03-03 | 4 | Loeillot Olivier — Chief Executive Officer, Director | Tax withholding (F): 344 @ $128.73 · Tax withholding (F): 1,610 @ $124.97 | EDGAR |
| 2026-03-03 | 4 | Bylund James — Chief Operating Officer | Tax withholding (F): 1,478 @ $128.73 · Tax withholding (F): 2,433 @ $124.97 | EDGAR |
| 2026-03-03 | 4 | Garland Jason K — CFO | Tax withholding (F): 327 @ $128.73 · Tax withholding (F): 715 @ $124.97 | EDGAR |
| 2026-03-03 | 4 | KURIYEL RALF — Senior VP, R&D | Tax withholding (F): 444 @ $128.73 · Tax withholding (F): 923 @ $124.97 | EDGAR |
| 2026-03-03 | 4 | Hunt Anthony — Director | Tax withholding (F): 9,897 @ $124.97 | EDGAR |
| 2026-01-12 | 4 | Douglass Brian Robb — CHIEF PRODUCT OFFICER | Grant/award (A): 2,288 @ $0 · Grant/award (A): 2,143 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | DAWES KAREN A — Director | Sale (S): 275 @ $161 | EDGAR |
| 2025-12-17 | 4 | MUIR GLENN P — Director | Option exercise (M): 3,366 @ $26.12 · Option exercise (M): 3,366 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Hunt Anthony — Director | Other (J): 2,000 | EDGAR |
| 2025-11-26 | 4 | Loeillot Olivier — Chief Executive Officer, Director | Sale (S): 7,041 @ $170 | EDGAR |
| 2025-11-19 | 4 | Bylund James — Chief Operating Officer | Sale (S): 2,191 @ $151.21 | EDGAR |
| 2025-11-14 | 4 | Hunt Anthony — Director | Sale (S): 1,784 @ $151.01 · Sale (S): 2,100 @ $152.17 · Sale (S): 2,923 @ $153.14 · Sale (S): 2,500 @ $154.32 · Sale (S): 3,000 @ $155.45 · Sale (S): 5,737 @ $156.22 · +3 more | EDGAR |
| 2025-11-13 | 4 | Hunt Anthony — Director | Option exercise (M): 25,000 @ $33.87 · Sale (S): 3,741 @ $154.92 · Sale (S): 4,740 @ $155.85 · Sale (S): 4,959 @ $156.65 · Sale (S): 11,096 @ $158.01 · Sale (S): 464 @ $158.51 · +1 more | EDGAR |
| 2025-10-06 | 4 | Loeillot Olivier — Chief Executive Officer, Director | Tax withholding (F): 1,248 @ $145.23 | EDGAR |
| 2025-09-26 | 4 | Garland Jason K — CFO | Tax withholding (F): 412 @ $121.68 | EDGAR |
| 2025-09-11 | 4 | Hunt Anthony — Director | Option exercise (M): 20,000 @ $33.87 · Sale (S): 96 @ $116.34 · Sale (S): 1,108 @ $118.32 · Sale (S): 3,262 @ $119.64 · Sale (S): 14,882 @ $120.19 · Sale (S): 7,584 @ $121.42 · +2 more | EDGAR |
| 2025-09-04 | 4 | Loeillot Olivier — Chief Executive Officer, Director | Tax withholding (F): 2,506 @ $116.18 | EDGAR |
| 2025-09-04 | 4 | Hughes Violetta — CHIEF ACCOUNTING OFFICER | Grant/award (A): 4,142 @ $0 · Grant/award (A): 3,914 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Madaus Martin D — Director | Purchase (P): 1,800 @ $112.13 | EDGAR |
| 2025-05-21 | 4 | BARTHELEMY NICOLAS — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Pax Margaret — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Mhatre Rohin — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Konstantinov Konstantin — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | EGLINTON MANNER CARRIE — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Madaus Martin D — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | DAWES KAREN A — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | MUIR GLENN P — Director | Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Hunt Anthony — Director | Sale (S): 2,043 @ $122.66 · Sale (S): 17,596 @ $123.57 · Sale (S): 6,533 @ $124.34 · Sale (S): 268 @ $125.20 · Sale (S): 7 @ $127 | EDGAR |
| 2025-04-02 | 4 | Bylund James — Chief Operating Officer | Tax withholding (F): 454 @ $128.50 | EDGAR |
Recent 8-K events — REPLIGEN CORP
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-15 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →